Nymox Pharmaceutical
NYMX
#9952
Rank
A$29.46 M
Marketcap
Country
$0.32
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.35 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$10.54 Million, an increase over its 2021 earnings that were of -A$20.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.35 Million-68.25%
2022 -A$10.54 Million-47.71%
2021 -A$20.15 Million6.61%
2020 -A$18.9 Million-10.91%
2019 -A$21.22 Million24.24%
2018 -A$17.08 Million-20.03%
2017 -A$21.36 Million2.71%
2016 -A$20.79 Million-63.86%
2015 -A$57.53 Million674.44%
2014 -A$7.43 Million-6.11%
2013 -A$7.92 Million-35.66%
2012 -A$12.3 Million-20.76%
2011 -A$15.52 Million38.33%
2010 -A$11.22 Million35.59%
2009 -A$8.28 Million11.8%
2008 -A$7.41 Million-12.94%
2007 -A$8.51 Million8.85%
2006 -A$7.81 Million36.5%
2005 -A$5.73 Million-4.4%
2004 -A$5.99 Million-14.58%
2003 -A$7.01 Million
2001 -A$5.14 Million-20.54%
2000 -A$6.47 Million21.72%
1999 -A$5.32 Million-25.56%
1998 -A$7.14 Million101.3%
1997 -A$3.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$10.94 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.20 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.79 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.38 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.69 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA